Vaccines

Third Trimester Maternal Vaccination Against Pertussis Protective for Infants

Third Trimester Maternal Vaccination Against Pertussis Protective for Infants

By

Maternal vaccination against pertussis between 27 and 36 weeks of gestation was associated with a high percentage of newborns with protective pertussis antibody concentrations.

ACIP Votes in Favor of Heplisav-B for Hepatitis B Prevention in Adults

ACIP Votes in Favor of Heplisav-B for Hepatitis B Prevention in Adults

By

The FDA approval of Heplisav-B was based on data from 3 phase 3 noninferiority trials involving close to 10,000 adults who received the vaccine.

ACIP: New Recommendations for Herpes Zoster Vaccine Administration

ACIP: New Recommendations for Herpes Zoster Vaccine Administration

By

The Advisory Committee on Immunization Practices has provided 3 new recommendations to supplement its original 2008 report, as well as a cost-effectiveness analysis from the CDC.

Higher Influenza Vaccination Uptake Associated With Provider Recommendations

Higher Influenza Vaccination Uptake Associated With Provider Recommendations

By

A new study indicates that early-season influenza vaccination coverage was significantly higher among adults aged ≥18 years with a provider visit and recommendation/offer for vaccination.

Meningococcal Serogroup B Vaccine Safe, Effective Short-Term in Children, Adolescents

Meningococcal Serogroup B Vaccine Safe, Effective Short-Term in Children, Adolescents

By

In the overall comparative meta-analyses, the multicomponent meningococcal serogroup B vaccine had increased immunogenicity (short-term and persistent) compared with recombinant meningococcal serogroup B vaccine against strain NZ98/254.

Influenza Activity Dominated by H3N2 Viruses, Vaccine Only 25% Effective

Influenza Activity Dominated by H3N2 Viruses, Vaccine Only 25% Effective

By

Early treatment with neuraminidase inhibitor antiviral medications is recommended for patients with severe, complicated, or progressive influenza illness and those at higher risk for influenza complications, including adults aged ≥65 years who develop influenza symptoms.

Influenza vaccine not associated with increased risk of epilepsy in children

No increased risk of incident epilepsy was seen among children who received influenza vaccination during the 2009-2010 influenza season in Norway.

ACIP: 2018 Immunization Schedule for Children, Adolescents Released

ACIP: 2018 Immunization Schedule for Children, Adolescents Released

By

The ACIP has released the 2018 Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger.

ACIP: 2018 Adult Immunization Schedule Now Available

ACIP: 2018 Adult Immunization Schedule Now Available

By

The ACIP has released the 2018 Recommended Immunization Schedule for Adults Aged 19 Years or Older.

Trends of <i>S pneumoniae, H influenzae</i> Antibiotic Resistance in Children

Trends of S pneumoniae, H influenzae Antibiotic Resistance in Children

By

Study analyzed the trends of nasopharyngeal carriage and antibiotic resistance of Streptococcus pneumoniae, Haemophilus influenza, and Moraxella catarrhalis isolated from young children with acute otitis media during a 16-year period.

Zika Virus Vaccine Progresses Into Phase 1 Clinical Trial

Zika Virus Vaccine Progresses Into Phase 1 Clinical Trial

By

An investigational Zika virus vaccine was granted Fast Track designation by the FDA.

PCV13 Vaccine Elicits Small, Transient Reduction in Pneumococcal Carriage in Adults

PCV13 Vaccine Elicits Small, Transient Reduction in Pneumococcal Carriage in Adults

By

A single dose of PCV13 was found to be effective in generating a small, temporary reduction in vaccine-type nasopharyngeal pneumococcal carriage in older, community-dwelling residents.

Patient Reminders, Recall Systems Increase Immunization Rates

Patient Reminders, Recall Systems Increase Immunization Rates

Patient reminder and recall systems seem to be effective for improving receipt of immunizations.

Repeat Influenza Vaccination Effective in Preventing Severe Influenza in Elderly

Repeat Influenza Vaccination Effective in Preventing Severe Influenza in Elderly

By

Prevention of severe and fatal infection caused by influenza was observed mainly in patients who were vaccinated in both the current and previous seasons, reinforcing the recommendation of annual vaccination in older adults.

ACIP Recommends Third Dose of MMR Vaccine for People With Increased Risk

ACIP Recommends Third Dose of MMR Vaccine for People With Increased Risk

By

Individuals who have previously received 2 doses of a mumps-containing vaccine should receive a third dose if at increased risk for developing mumps.

ACIP Issues Updated Recommendations for Preventing HBV Infection

ACIP Issues Updated Recommendations for Preventing HBV Infection

By

The Advisory Committee on Immunization Practices has issued updated recommendations for HBV prevention.

Influenza Vaccine in Children: Recommendations From the AAP

Influenza Vaccine in Children: Recommendations From the AAP

By

Providers may continue to offer vaccines until June 30 of every year, the date marking the end of the influenza season, because influenza is unpredictable.

Cost-Effectiveness of New Adjuvanted Herpes Zoster Subunit Vaccine

Cost-Effectiveness of New Adjuvanted Herpes Zoster Subunit Vaccine

By

At a price of $280 per series, the adjuvanted herpes zoster subunit vaccine would cost less than the live attenuated herpes zoster vaccine and has a high probability of offering good value.

New Two-Dose Hepatitis B Vaccine for Adults Now Available

New Two-Dose Hepatitis B Vaccine for Adults Now Available

By

Dynavax Technologies announced the availability of a two-dose hepatitis B vaccine for adults.

Delaying Rotavirus Vaccination Until Discharge Leads to Missed Opportunities

Delaying Rotavirus Vaccination Until Discharge Leads to Missed Opportunities

By

Study found that many hospitalized infants did not receive rotavirus vaccination before discharge and were no longer age-eligible for vaccination after discharge from the hospital.

Strategies for Preventing Group B Streptococcus in Infants

Strategies for Preventing Group B Streptococcus in Infants

By

Expert from the National Center for Immunization and Respiratory Diseases, a division of the CDC, discusses prevention strategies for group B streptococcus in infants, including the development of a maternal vaccine.

Over one-third of U.S. HIV patients are not vaccinated against hepatitis B

One third of HIV patients in the United States (U.S.) remain unvaccinated against hepatitis B. Of HIV patients who were candidates for hepatitis B vaccination, only 1 in 10 were vaccinated within 1 year of continuing care for HIV.

Meningococcal B Vaccine Elicits Bactericidal Responses Against Diverse Strains

Meningococcal B Vaccine Elicits Bactericidal Responses Against Diverse Strains

By

MenB-FHbp was safe and immunogenic after dose 2 and dose 3 and was also associated with more injection-site reactions than hepatitis A virus vaccine and saline.

State-Mandated Counseling Lowers Vaccine Exemption Rates

State-Mandated Counseling Lowers Vaccine Exemption Rates

Mandated counseling to obtain a vaccine exemption was associated with a decrease in exemption rates and an increase in vaccine coverage.

Herpes zoster subunit vaccine may be more cost-effective than live attenuated zoster vaccine

The new adjuvanted herpes zoster subunit vaccine was more efficacious and less expensive for all ages at the price of $280 per series as compared to the single-dose herpes zoster vaccine.

Universal Influenza Vaccine: A Game Changer in Prevention

Universal Influenza Vaccine: A Game Changer in Prevention

By

A dedicated research effort led by NIH's National Institute of Allergy and Infectious Diseases is aimed at developing a universal influenza vaccine that would confer better and longer-lasting protection against influenza virus strains.

Guideline Update for Influenza Vaccine in Patients With Egg Allergy

Guideline Update for Influenza Vaccine in Patients With Egg Allergy

By

A new guideline states patients with an egg allergy do not need to avoid or take special precautions when receiving the influenza vaccine.

Safety, Efficacy of 2 Zika Virus Vaccine Trials Reported

Safety, Efficacy of 2 Zika Virus Vaccine Trials Reported

By

Two trials assessing different vaccination schedules and delivery methods for Zika virus vaccine reveal the vaccines to be safe, well tolerated, and immunogenic.

Trends in Meningococcal Disease Following MenACWY Vaccine Introduction

Trends in Meningococcal Disease Following MenACWY Vaccine Introduction

By

Incidence of meningococcal disease in the United States has decreased across all age groups.

Serological Response to PCV13, PPV23 Vaccination Varies According to Individual Biologic in RA

Serological Response to PCV13, PPV23 Vaccination Varies According to Individual Biologic in RA

By

The objective of the study was to evaluate initial serologic responses to the 13-valent protein-conjugated and the 23-valent polysaccharide pneumococcal vaccine.

Sign Up for Free e-newsletters